Erschienen in:
01.03.2010 | Letter to the editors
Use of the muscle volume analyzer to evaluate enzyme replacement therapy in late-onset Pompe disease
verfasst von:
Fuminobu Sugai, Yosuke Kokunai, Yoichi Yamamoto, Goichi Hashida, Kengo Shimazu, Masahito Mihara, Satoru Inoue, Saburo Sakoda
Erschienen in:
Journal of Neurology
|
Ausgabe 3/2010
Einloggen, um Zugang zu erhalten
Abstract
The muscle volume analyzer (MVA) can predict limb muscle weight based on bioelectric impedance analysis, whereas the conventional handheld dynamometer (HHD) measures muscle strength. In this study, a 26-year-old female on invasive ventilation due to late-onset Pompe disease was treated with enzyme replacement therapy (ERT) for 12 months. MVA measurements demonstrated time-dependent improvement from the baseline compared to HHD measurements, showing remarkably fluctuating muscle strength. Thus, the MVA can be used as an alternative, particularly for patients suffering from severe limb muscle weakness.